The Lancet May 5 2018 FDA Pimavanserin review

The Lancet Feb 23 2018 Canada Cannabis

With the deadline for legalization of nonmedical marijuana approaching, scientists studying the health impacts of cannabis are calling on the federal government to implement a comprehensive research program. “Considerably more …

Spending by Canadian governments on patented drugs costing more than $10 000 per patient annually increased 60% in 2016 . Spending on brand-name pharmaceuticals as a whole rose 18%.

Over the past decade, the share of food bank users over age 65 increased from 3% to 7% in Toronto. Last year alone, there was a 27% jump in seniors …

Twenty years after a federal advisory committee called for a nationwide health information system to support clinical decision-making, the Northwest Territories is on the verge of achieving the elusive dream of having …